Global Prophylactic Gamma Globulin Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Prophylactic Gamma Globulin Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
The gamma globulin fraction of pooled normal human sera has a wide range of usefulness in the prophylaxis of many infectious diseases. Hyperimmune human globulin preparations are effective against certain other illnesses in which globulins pooled from normal sera contain insufficient antibody.
Prophylactic Gamma Globulin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Prophylactic Gamma Globulin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Immunodeficiency and Autoimmune Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Prophylactic Gamma Globulin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Prophylactic Gamma Globulin key manufacturers include Baxter, Grifols, Octapharma, Biotest, Kedrion Biopharma, Takeda, ADMA Biologics, BPL and LFB Group, etc. Baxter, Grifols, Octapharma are top 3 players and held % sales share in total in 2022.
Prophylactic Gamma Globulin can be divided into IVIg Liquid and IVIg Powder, etc. IVIg Liquid is the mainstream product in the market, accounting for % sales share globally in 2022.
Prophylactic Gamma Globulin is widely used in various fields, such as Immunodeficiency, Autoimmune Disease and Acute Infection,, etc. Immunodeficiency provides greatest supports to the Prophylactic Gamma Globulin industry development. In 2022, global % sales of Prophylactic Gamma Globulin went into Immunodeficiency filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prophylactic Gamma Globulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Baxter
Grifols
Octapharma
Biotest
Kedrion Biopharma
Takeda
ADMA Biologics
BPL
LFB Group
Hualan Biological
Beijing Tiantan Biological
Beijing Bohui Innovation Biotechnology
Pacific Shuanglin Bio-pharmacy
Shenzhen Weiguang Biological
CBPO
CNBG
Shanghai RAAS
Sichuan Yuanda Shuyang
Segment by Type
IVIg Liquid
IVIg Powder
Immunodeficiency
Autoimmune Disease
Acute Infection
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Prophylactic Gamma Globulin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Prophylactic Gamma Globulin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Prophylactic Gamma Globulin industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Prophylactic Gamma Globulin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Prophylactic Gamma Globulin introduction, etc. Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Prophylactic Gamma Globulin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Prophylactic Gamma Globulin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Prophylactic Gamma Globulin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Immunodeficiency and Autoimmune Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Prophylactic Gamma Globulin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Prophylactic Gamma Globulin key manufacturers include Baxter, Grifols, Octapharma, Biotest, Kedrion Biopharma, Takeda, ADMA Biologics, BPL and LFB Group, etc. Baxter, Grifols, Octapharma are top 3 players and held % sales share in total in 2022.
Prophylactic Gamma Globulin can be divided into IVIg Liquid and IVIg Powder, etc. IVIg Liquid is the mainstream product in the market, accounting for % sales share globally in 2022.
Prophylactic Gamma Globulin is widely used in various fields, such as Immunodeficiency, Autoimmune Disease and Acute Infection,, etc. Immunodeficiency provides greatest supports to the Prophylactic Gamma Globulin industry development. In 2022, global % sales of Prophylactic Gamma Globulin went into Immunodeficiency filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prophylactic Gamma Globulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Baxter
Grifols
Octapharma
Biotest
Kedrion Biopharma
Takeda
ADMA Biologics
BPL
LFB Group
Hualan Biological
Beijing Tiantan Biological
Beijing Bohui Innovation Biotechnology
Pacific Shuanglin Bio-pharmacy
Shenzhen Weiguang Biological
CBPO
CNBG
Shanghai RAAS
Sichuan Yuanda Shuyang
Segment by Type
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Prophylactic Gamma Globulin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Prophylactic Gamma Globulin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Prophylactic Gamma Globulin industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Prophylactic Gamma Globulin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Prophylactic Gamma Globulin introduction, etc. Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Prophylactic Gamma Globulin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.